tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DRMA Stock Latest News

Dermata Therapeutics to reveal brand name for OTC skincare business
The FlyDermata Therapeutics to reveal brand name for OTC skincare business
4h ago
DRMA
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
PremiumRatings
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
9d ago
DRMA
Dermata Therapeutics files $100M mixed securities shelf
PremiumThe Fly
Dermata Therapeutics files $100M mixed securities shelf
10d ago
DRMA
Dermata Therapeutics Ends License Agreement with Villani
PremiumCompany Announcements
Dermata Therapeutics Ends License Agreement with Villani
16d ago
8K
DRMA
Dermata Therapeutics Shifts Focus to OTC Skincare
PremiumCompany Announcements
Dermata Therapeutics Shifts Focus to OTC Skincare
20d ago
8K
DRMA
Dermata Therapeutics Increases Stock Offering by $1.79M
PremiumCompany AnnouncementsDermata Therapeutics Increases Stock Offering by $1.79M
27d ago
8K
DRMA
Dermata says Australian Patent Office accepts Spongilla tech application
Premium
The Fly
Dermata says Australian Patent Office accepts Spongilla tech application
2M ago
DRMA
Dermata Therapeutics Presents Promising Phase 3 Trial Results
Premium
Company Announcements
Dermata Therapeutics Presents Promising Phase 3 Trial Results
3M ago
8K
DRMA
Dermata Shifts Focus to Over-the-Counter Dermatology
PremiumCompany Announcements
Dermata Shifts Focus to Over-the-Counter Dermatology
3M ago
8K
DRMA
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
PremiumThe Fly
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
3M ago
DRMA
Dermata Therapeutics withdraws IND application for XYNGARI
PremiumThe Fly
Dermata Therapeutics withdraws IND application for XYNGARI
3M ago
DRMA
Dermata Therapeutics Regains Nasdaq Compliance by August 2025
PremiumCompany Announcements
Dermata Therapeutics Regains Nasdaq Compliance by August 2025
3M ago
8K
DRMA
Dermata Therapeutics price target lowered to $10 from $30 at Maxim
PremiumThe FlyDermata Therapeutics price target lowered to $10 from $30 at Maxim
4M ago
DRMA
Dermata Therapeutics Reports Positive Phase 3 Trial Results
Premium
Company Announcements
Dermata Therapeutics Reports Positive Phase 3 Trial Results
4M ago
8K
DRMA
Dermata Therapeutics Inc trading halted, news pending
Premium
The Fly
Dermata Therapeutics Inc trading halted, news pending
4M ago
DRMA
Dermata Therapeutics Announces Reverse Stock Split
PremiumCompany Announcements
Dermata Therapeutics Announces Reverse Stock Split
4M ago
8K
DRMA
Dermata Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
Dermata Therapeutics Holds Annual Stockholders Meeting
5M ago
8K
DRMA
Dermata Therapeutics receives notice of grant of Australian patent
PremiumThe Fly
Dermata Therapeutics receives notice of grant of Australian patent
5M ago
DRMA
Dermata Faces Nasdaq Delisting Risk, Plans Stock Split
PremiumCompany Announcements
Dermata Faces Nasdaq Delisting Risk, Plans Stock Split
5M ago
8K
DRMA
Dermata Therapeutics Begins Manufacturing for STAR-2 Trial
PremiumCompany AnnouncementsDermata Therapeutics Begins Manufacturing for STAR-2 Trial
7M ago
8K
DRMA
Dermata Therapeutics price target lowered to $3 from $6 at Maxim
Premium
The Fly
Dermata Therapeutics price target lowered to $3 from $6 at Maxim
7M ago
DRMA
Dermata Faces Nasdaq Delisting Risk Over Bid Price
Premium
Company Announcements
Dermata Faces Nasdaq Delisting Risk Over Bid Price
7M ago
8K
DRMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >